S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ORIC Oric Pharmaceuticals Inc

8.96

0.00 (0.00%)

Pre Market

Last Updated: 20:05:05

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Oric Pharmaceuticals Charts.

Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Oric Pharmaceuticals Charts.

Oric Pharmaceuticals Inc News

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Tuesday 26 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (4 weeks ago) • Edgar (US Regulatory)

ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates
Wednesday 13 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Saturday 9 November 2024 (1 month ago) • Edgar (US Regulatory)

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Tuesday 5 November 2024 (1 month ago) • GlobeNewswire Inc.

ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Saturday 2 November 2024 (1 month ago) • GlobeNewswire Inc.

ORIC® Pharmaceuticals Presents Data Further Supporting Potential Best-In-Class Profile of ORIC-114 to Treat EGFR Exon 20 Insertions and Other Atypical Mutations at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Wednesday 23 October 2024 (2 months ago) • GlobeNewswire Inc.

ORIC® Pharmaceuticals Announces Presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Thursday 10 October 2024 (2 months ago) • GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Saturday 5 October 2024 (2 months ago) • GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Saturday 7 September 2024 (3 months ago) • GlobeNewswire Inc.

More Oric Pharmaceuticals Inc News Articles

Verizon Communications

Newcrest Mining

JP Morgan Chase

Australian SE All Ordina...

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions